Ensysce Biosciences, Inc (ENSC): Price and Financial Metrics
ENSC Price/Volume Stats
| Current price | $2.02 | 52-week high | $14.67 |
| Prev. close | $2.13 | 52-week low | $1.62 |
| Day low | $2.02 | Volume | 43,056 |
| Day high | $2.12 | Avg. volume | 963,535 |
| 50-day MA | $2.30 | Dividend yield | N/A |
| 200-day MA | $5.08 | Market Cap | 4.79M |
ENSC Stock Price Chart Interactive Chart >
Ensysce Biosciences, Inc (ENSC) Company Bio
Ensysce Biosciences, Inc., a clinical-stage biotech company, engages in developing various prescription drugs. The company is developing tamper-proof opioids using Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms. Its products treat severe pain and assist in preventing deaths caused by opioid abuse. The company is based in La Jolla, California.
ENSC Price Returns
| 1-mo | -9.62% |
| 3-mo | -41.45% |
| 6-mo | -75.06% |
| 1-year | -75.31% |
| 3-year | -99.87% |
| 5-year | -100.00% |
| YTD | -75.18% |
| 2024 | -48.81% |
| 2023 | -88.22% |
| 2022 | -99.20% |
| 2021 | -62.20% |
| 2020 | -94.03% |
Loading social stream, please wait...